Author

Mary E. Barry

Observed name: Mary E Barry

Institution: Mayo Clinic

Observed institutions: Mayo Clinic, Baylor College of Medicine

OpenAlex ID: A5112332002

Role of Endogenous Endonucleases and Tissue Site in Transfection and CpG-Mediated Immune Activation after Naked DNA Injection

1999 · Mary E. Barry, Dasein Pinto-Gonzalez, et al. · Human Gene Therapy · 173

Cryo-EM structure of human adenovirus D26 reveals the conservation of structural organization among human adenoviruses

2017 · Xiaodi Yu, David Veesler, et al. · Science Advances · 78

Evaluation of polymer shielding for adenovirus serotype 6 (Ad6) for systemic virotherapy against human prostate cancers

2016 · Tien V Nguyen, Greg J Heller, et al. · Molecular Therapy — Oncolytics · 28

Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer

2018 · Tien V Nguyen, Catherine M Crosby, et al. · Oncolytic Virotherapy · 21

Retargeted and detargeted adenovirus for gene delivery to the muscle

2017 · Tien V. Nguyen, Stephanie S. Anguiano-Zarate, et al. · Virology · 19

Comparison of replicating and nonreplicating vaccines against SARS-CoV-2

2022 · Haley E. Mudrick, Shane Massey, et al. · Science Advances · 15

Comparison of Adenoviruses as Oncolytics and Cancer Vaccines in an Immunocompetent B Cell Lymphoma Model

2011 · Eric A. Weaver, Christopher Y. Chen, et al. · Human Gene Therapy · 12

Structure-derived insights from blood factors binding to the surfaces of different adenoviruses

2024 · Haley E. Mudrick, Shao-Chia Lu, et al. · Nature Communications · 8

Comparison of Mucosal and Intramuscular Immunization against SARS-CoV-2 with Replication-Defective and Replicating Single-cycle Adenovirus Vaccines

2021 · Haley E. Mudrick, Erin B. McGlinch, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 4

Structural requirements of blood factors binding to soluble hexon trimers with implications for adenovirus cell targeting and immune evasion

2026 · Olivia X. Ma, Shao-Chia Lu, et al. · PLoS Pathogens

Immune shielding of viral vectors via capsid engineering with genetically encoded zwitterionic peptides

2026 · Shao-Chia Lu, Olivia X. Ma, et al. · Molecular Therapy Advances

Works count: 15

Citation count: 377

H-index: 8

I10-index: 8